Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture

A RABINOVITCH, W SUMOSKI… - The Journal of …, 1990 - academic.oup.com
A RABINOVITCH, W SUMOSKI, RV RAJOTTE, GL WARNOCK
The Journal of Clinical Endocrinology & Metabolism, 1990academic.oup.com
Interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon-γ (IFNγ) inhibit insulin release
and may be cytotoxic to isolated rodent pancreatic islets. In this study we examined the
effects of IL-1, TNF, and IFNγ on the viability and hormone secretion of islets isolated from
adult human pancreas and maintained in monolayer culture. IL-1 and TNF were cytotoxic to
the islet cells (20-30% cell lysis) in a 51Cr release cytotoxicity assay, and IFNγ had only
small effects (< 10% lysis). Combination of maximally cytotoxic concentrations of IL-1 (10 …
Interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon-γ (IFNγ) inhibit insulin release and may be cytotoxic to isolated rodent pancreatic islets. In this study we examined the effects of IL-1, TNF, and IFNγ on the viability and hormone secretion of islets isolated from adult human pancreas and maintained in monolayer culture. IL-1 and TNF were cytotoxic to the islet cells (20-30% cell lysis) in a 51Cr release cytotoxicity assay, and IFNγ had only small effects (<10% lysis). Combination of maximally cytotoxic concentrations of IL-1 (10 U/mL) and TNF (103 U/mL) produced an additive cytotoxic effect. IFNγ (103 U/mL) acted synergistically with IL-1 and TNF, and the three cytokines added together produced maximal islet cell lysis (46.4 ± 4.3%). Assay of insulin and glucagon in the islet monolayers revealed that IL-1, TNF, and IFNγ inhibited both B- and A-cell secretory functions; however, only IL-1 and TNF produced permanent decreases in insulin and glucagon contents in the islet cultures. These findings indicate that IL-1 and TNF, as single agents, are cytotoxic to human islet cells, and that this cytotoxicity can be amplified by combining the cytokines and/or adding IFNγ. However, the lack of specificity for B-cells in vitro suggests that additional factors might be operative in vivo for the cytokine products of macrophages and lymphocytes infiltrating islets to produce the B-cell-specific damage characteristic of type 1 diabetes.
Oxford University Press